Taqman Genotyping Assays Can Be Used on Decalcified and Paraffin-Embedded Tissue From Patients With Osteosarcoma
Taqman Genotyping Assays Can Be Used on Decalcified and Paraffin-Embedded Tissue From Patients With Osteosarcoma
复制标题
Taqman 基因分型测定可用于骨肉瘤患者的脱钙组织和石蜡包埋组织
DOI:
10.1002/pbc.22654
复制
发表时间:
2011-01-01
影响因子:
3.2
通讯作者:
Hoogerbrugge, Peter M.
中科院分区:
文献类型:
--
作者:
Hagleitner, Melanie M.;Coenen, Marieke J. H.;Hoogerbrugge, Peter M.
Background In cancers like osteosarcoma with a 5 year over all survival of 50-60%, archived histological specimens can be a useful source of biological material However this material generally has been decalcified and formalin fixed for many years In our study, we investigated whether DNA obtained from these tissues can be used for reliable single nucleotide polymorphism (SNP) genotyping Procedure We studied two SNPs in the drug transporter MDR1 using Taqman (R) SNP genotyping assays Genotypes of the germ line DNA derived from freshly isolated DNA of 20 surviving patients with osteosarcoma were compared with genotypes obtained from archived material from decalcified formalin fixed, paraffin embedded (FFPE) blocks of the same patients Results Decalcified FFPE derived DNA yielded smaller PCR fragments compared to DNA extracted from peripheral blood cells, with a reliable size of 200 bp However, we were able to evaluate each SNP in 19 of 20 cases included in this study All successfully genotyped samples showed 100% concordance between genotypes obtained from DNA of FFPE tissue and the genotypes obtained from DNA of blood from the same patients Conclusions In conclusion we have demonstrated that decalcified FFPE tissue can be used for genetic polymorphism analysis using Taqman (R) allelic discrimination assays This forms a unique opportunity to combine new insights in genetic research with historical patient cohorts Pediatr Blood Cancer 2011 56 35-38 (C) 2010 Wiley Liss Inc